Brian G. Drazba
2014 - Heron Therapeutics
In 2014, Brian G. Drazba earned a total compensation of $607.6K as Vice President, Finance and Chief Financial Officer at Heron Therapeutics, a 35% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $79,088 |
|---|---|
| Option Awards | $243,502 |
| Salary | $285,000 |
| Total | $607,590 |
Drazba received $285K in salary, accounting for 47% of the total pay in 2014.
Drazba also received $79.1K in non-equity incentive plan and $243.5K in option awards.
Rankings
In 2014, Brian G. Drazba's compensation ranked 9,619th out of 13,032 executives tracked by ExecPay. In other words, Drazba earned more than 26.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,619 out of 13,032 | 26th |
Division Manufacturing | 3,635 out of 4,965 | 27th |
Major group Chemicals And Allied Products | 1,240 out of 1,690 | 27th |
Industry group Drugs | 983 out of 1,369 | 28th |
Industry Pharmaceutical Preparations | 754 out of 1,042 | 28th |
Source: SEC filing on April 29, 2016.
Drazba's colleagues
We found three more compensation records of executives who worked with Brian G. Drazba at Heron Therapeutics in 2014.